Fenimore Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Fenimore Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-9,050	Closed	-$690K	–	125
2019 Q3	$690K	Hold	9,050	–	–	0.02%	88
2019 Q2	$794K	Hold	9,050	–	–	0.03%	89
2019 Q1	$819K	Hold	9,050	–	–	0.03%	87
2018 Q4	$649K	Hold	9,050	–	–	0.03%	89
2018 Q3	$868K	Hold	9,050	–	–	0.03%	88
2018 Q2	$861K	Buy	+9,050	New	+$832K	0.03%	88

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

Fenimore Asset Management's XBI Position: Q4 2019 in Review

Fenimore Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2019, closing a stake of 9,050 shares — an estimated $690K sold.

Fenimore Asset Management first reported a position in XBI in Q2 2018 and held it in 6 quarters. The position peaked at $868K in Q3 2018. 474 funds tracked by Wall St. Rank hold XBI as of Q4 2019.

Fenimore Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2019 after selling out during the quarter.
Fenimore Asset Management sold 9,050 State Street SPDR S&P Biotech ETF shares in Q4 2019, an estimated $690K.
Fenimore Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and held it in 6 quarters.
Fenimore Asset Management's State Street SPDR S&P Biotech ETF position peaked at $868K in Q3 2018.
474 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2019.

Based on Fenimore Asset Management's 13F filing for Q4 2019, filed 16 Jan 2020.